John L. Higgins, Director at LIGAND PHARMACEUTICALS INC (LGND), sold 10,000 shares at $61.87 ($619K) on 2022-12-16, disclosed to the SEC on 2022-12-20.
Open-market sale of $619k LGND by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| OABI | BUY | 2025-03-21 | $9K | — | Filing → |
| OABI | BUY | 2025-03-20 | $591K | — | Filing → |
| TECH | SELL | 2024-05-16 | $335K | — | Filing → |